-
公开(公告)号：KR1020110125962A
公开(公告)日：2011-11-22
申请号：KR1020100045621
申请日：2010-05-14
Applicant: 한국식품연구원
IPC: A61K36/27 , A61K36/704 , A61P9/00
Abstract: PURPOSE: A pharmaceutical composition containing Cynanchum wilfordii extract is provided to reduce blood pressure and to prevent and treat hypertension. CONSTITUTION: A pharmaceutical composition for reducing blood pressure contains Cynanchum wilfordii ethanol extract as an active ingredient. A functional food with an activity of reducing blood pressure contains 0.02-50 wt% of the Cynanchum wilfordii ethanol extract as an active ingredient. The pharmaceutical composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, external use formulation, supporsitory, and sterilization injection solution. The Cynanchum wilfordii extract is administered in 0.0001-100mg/kg a day.
Abstract translation: 目的：提供含有西葫芦提取物的药物组合物，以降低血压和预防和治疗高血压。 构成：用于降低血压的药物组合物含有Cynanchum wilfordii乙醇提取物作为活性成分。 具有降低血压活性的功能性食品含有作为活性成分的Cynanchum wilfordii乙醇提取物的0.02〜50重量％。 药物组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，外用制剂，促进剂和杀菌注射溶液的形式制备。 Cynanchum wilfordii提取物每天以0.0001-100mg / kg施用。
-
公开(公告)号：KR1020110125960A
公开(公告)日：2011-11-22
申请号：KR1020100045618
申请日：2010-05-14
Applicant: 한국식품연구원
IPC: A61K36/27 , A61K36/704 , A61P7/02
Abstract: PURPOSE: A pharmaceutical composition containing Cynanchum wilfordii extract for reducing blood clot is provided to prevent and relieve heart diseases and stroke. CONSTITUTION: A pharmaceutical composition for reducing blood clot contains 0.02-50 wt% of Cynanchum wilfordii ethanol extract as an active ingredient. The Cynanchum wilfordii extract is prepared by washing, drying, and pulverizing Cynanchum wilfordii and isolating Cynanchum wilfordii using 70-90% ethanol at 90-98°C for 5-7 hours.
Abstract translation: 目的：提供含有枸杞子提取物用于减少血块的药物组合物，以预防和缓解心脏病和中风。 构成：用于减少血块的药物组合物含有0.02-50重量％的Cynanchum wilfordii乙醇提取物作为活性成分。 通过洗涤，干燥和粉碎，藜，并使用70-90％乙醇在90-98℃下分离Cynanchum wilfordii 5-7小时来制备C藜提取物。
-
公开(公告)号：KR1020110125961A
公开(公告)日：2011-11-22
申请号：KR1020100045620
申请日：2010-05-14
Applicant: 한국식품연구원
IPC: A61K36/704 , A61K36/27 , A61P9/00
CPC classification number: A61K36/704 , A23V2200/326 , A61K2236/333
Abstract: PURPOSE: A pharmaceutical composition containing Polygonum multiflorum extract for lowering blood pressure is provided to prevent and treat hypertension. CONSTITUTION: A pharmaceutical composition for reducing blood pressure contains Polygonum multiflorum ethanol extract as an active ingredient. The ethanol is 70-90% ethanol. A functional food with an activity of reducing blood pressure contains Polygonum multiflorum ethanol extract as an active ingredient. A pharmaceutical composition for reducing blood pressure contains 0.02-50 wt% of the Polygonum multiflorum extract. The pharmaceutical composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, external use formulation, and suppository.
Abstract translation: 目的：提供含有降低血压的茯苓提取物的药物组合物，用于预防和治疗高血压。 构成：用于降低血压的药物组合物含有枸杞多酚乙醇提取物作为活性成分。 乙醇为70-90％乙醇。 具有降低血压活性的功能性食品含有枸杞多酚乙醇提取物作为活性成分。 用于降低血压的药物组合物含有茯苓提取物的0.02-50重量％。 药物组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，外用制剂和栓剂的形式制备。
-
公开(公告)号：KR1020110125958A
公开(公告)日：2011-11-22
申请号：KR1020100045616
申请日：2010-05-14
Applicant: 한국식품연구원
IPC: A61K36/27 , A61K36/704 , A61P3/00
CPC classification number: Y02A50/411
Abstract: PURPOSE: A pharmaceutical composition containing Cynanchum wilfordii extract for reducing blood cholesterol is provided to prevent and treat hypercholesterolemia. CONSTITUTION: A pharmaceutical composition for reducing blood cholesterol contains 0.02-50 wt% of Cynanchum wilfordii ethanol extract as an active ingredient. The ethanol is 70-90% ethanol. The Cynanchum wilfordii ethanol extract is prepared by washing, drying, and pulverizing Cynanchum wilfordii and extracting at 90-98°C for five to seven hours, and concentrating. The pharmaceutical composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, external use formulation, and suppository.
Abstract translation: 目的：提供含有Cynanchum wilfordii提取物降低血液胆固醇的药物组合物，用于预防和治疗高胆固醇血症。 构成：用于降低血液胆固醇的药物组合物含有0.02〜50重量％的枸杞子乙醇提取物作为活性成分。 乙醇为70-90％乙醇。 Cynanchum wilfordii乙醇提取物是通过洗涤，干燥和粉碎Cynanchum wilfordii并在90-98℃下提取五至七小时并进行浓缩制备的。 药物组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，外用制剂和栓剂的形式制备。
-
Patent Agency Ranking
公开(公告)号：KR1020110125959A
公开(公告)日：2011-11-22
申请号：KR1020100045617
申请日：2010-05-14
Applicant: 한국식품연구원
IPC: A61K36/704 , A61P7/02
CPC classification number: A61K36/704 , A23V2200/326 , A61K2236/333 , Y10S514/822
Abstract: PURPOSE: A pharmaceutical composition containing Polygonum multiflorum extract for reducing blood clot is provided to prevent and relieve adult diseases such as heart disease and stroke. CONSTITUTION: A pharmaceutical composition for reducing blood clot contains Polygonum multiflorum ethanol extract as an active ingredient. The ethanol is 70-90% ethanol. A functional food with an activity of reducing blood clot contains the Polygonum multiflorum ethanol extract as an active ingredient. The Polygonum multiflorum extract is contained in 0.02-50 wt% based on total pharmaceutical composition. The pharmaceutical composition is manufactured in the form of powder, granules, tablets, capsules, suspensions, syrup, external use formulation, and suppository.
Abstract translation: 目的：提供一种含有减少血块的茯苓提取物的药物组合物，用于预防和缓解成人疾病如心脏病和中风。 构成：用于减少血块的药物组合物含有枸杞多酚乙醇提取物作为活性成分。 乙醇为70-90％乙醇。 具有减少血块活性的功能性食品含有枸杞多酚乙醇提取物作为活性成分。 茯苓提取物含量为基于总药物组合物的0.02-50重量％。 药物组合物以粉末，颗粒，片剂，胶囊，悬浮液，糖浆，外用制剂和栓剂的形式制备。
-
公开(公告)号：KR101162141B1
公开(公告)日：2012-07-05
申请号：KR1020100045607
申请日：2010-05-14
Applicant: 한국식품연구원
IPC: A61K36/704 , A61K36/27 , A61P3/00
Abstract: 본 발명은 적하수오 추출물을 포함하는 혈중 콜레스테롤 저하용 약학 조성물에 관한 것으로, 더욱 상세하게 본 발명은 적하수오(
Polygonum
multiflorum ) 에탄올 추출물을 포함하는 혈중 콜레스테롤 저하용 약학 조성물, 적하수오를 세척, 건조 및 분쇄하고, 70 ~ 90% 에탄올을 가해 초고속 진공 저온 추출기로 90 ~ 98℃에서 5 ~ 7 시간 동안 추출한 후 농축하는 방법에 의해 수득되는 적하수오 에탄올 추출물의 제조방법 및 적하수오 에탄올 추출물을 포함하는 혈중 콜레스테롤 저하 활성을 갖는 기능성 식품을 제공한다.-
公开(公告)号：KR1020110125953A
公开(公告)日：2011-11-22
申请号：KR1020100045607
申请日：2010-05-14
Applicant: 한국식품연구원
IPC: A61K36/704 , A61K36/27 , A61P3/00
CPC classification number: A61K36/704 , A23V2200/3262 , A61K2236/333 , A61K2236/51
Abstract: PURPOSE: A pharmaceutical composition containing Polygonum multiflorum extract for reducing blood cholesterol is provided to prevent and relieve hypercholesterolemia. CONSTITUTION: A pharmaceutical composition for reducing blood cholesterol contains 0.02-50 wt% of Polygonum multiflorum ethanol extract as an active ingredient. The ethanol extract of Polygonum multiflorum is prepared by washing, drying, and pulverizing Polygonum multiflorum, isolating with a ultrahigh speed vacuum extractor of low temperature at 90-98°C for 5-7 hours, and concentrating. A functional food with activity of reducing blood cholesterol contains the ethanol extract as an active ingredient. The pharmaceutical composition is used in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, or sterilization injection solution.
Abstract translation: 目的：提供含有降低血液胆固醇的枸杞提取物的药物组合物，以预防和缓解高胆固醇血症。 构成：用于降低血液胆固醇的药物组合物含有0.02-50重量％的枸杞多酚乙醇提取物作为活性成分。 通过洗涤，干燥和粉碎Poly is制备Poly The的乙醇提取物，用超低速真空提取器在90-98℃下分离5-7小时，并浓缩。 具有降低血液胆固醇活性的功能性食品含有乙醇提取物作为活性成分。 药物组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆或灭菌注射溶液的形式使用。
-
公开(公告)号：KR1020110023015A
公开(公告)日：2011-03-08
申请号：KR1020090080585
申请日：2009-08-28
Applicant: 한국식품연구원
IPC: A61K36/70 , A61K36/282 , A61K36/725 , A61P7/02
CPC classification number: A61K36/704 , A61K36/282 , A61K36/725 , A61K2236/331 , A61K2236/51 , Y10S514/822
Abstract: PURPOSE: A composition for preventing or treating vascular diseases is provided to suppress HMA-coA reductase and ACE activity and to improve blood stream. CONSTITUTION: A composition for preventing or treating vascular diseases contains 0.01-88 weight% of Polygoni multiflori Radix extract, 2-16.33 weight% of Artemisia princes, 2-16.33 weight% of jujube, 2-16.33 weight% of Glycyrrhizae radix, 2-17 weight% of Cinnamomi Cortex spissus, 2-17 weight% of Zingiberis Rhizoma crudus and 2-17 weight% of Cassiae Semen. The Polygoni multiflori Radix extract is obtained by extracting Polygoni multiflori Radix with water and decompressing.
Abstract translation: 目的：提供用于预防或治疗血管疾病的组合物，以抑制HMA-coA还原酶和ACE活性并改善血流。 构成：用于预防或治疗血管疾病的组合物含有0.01-88重量％的黄芪提取物，2-16.33重量％的艾蒿，2-16.33重量％的枣，2-16.33重量％的甘草，2- 樟脑皮质痉挛17％，刺is草2-17％，焦糖精2-17％。 黄芪多花提取物通过提取Polygoni multiflori Radix与水和解压缩获得。
-
公开(公告)号：KR101041437B1
公开(公告)日：2011-06-15
申请号：KR1020090080585
申请日：2009-08-28
Applicant: 한국식품연구원
IPC: A61K36/70 , A61K36/282 , A61K36/725 , A61P7/02
Abstract: 본원발명은 혈관질환 예방 또는 개선용 조성물에 관한 것으로서, 하수오 추출물, 약쑥, 대추, 감초, 육계, 생강 및 결명자를 포함한다. 본원발명의 혈관질환 예방 또는 개선용 조성물은 항산화 활성이 우수할 뿐만 아니라, HMA-coA reductase 및 ACE의 활성을 억제하고, 혈전을 용해하는 효과가 있기 때문에 혈류를 개선하여 혈관질환을 예방 또는 개선하는 목적으로 유용하게 사용될 수 있다.
적하수오, 백하수오, 혈류 개선, 조성물
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.02 seconds)
